Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE, as well as has strategic clinical collaboration with Acepodia Inc. for the development of antibody-cell conjugation-based cell therapies in autoimmune diseases. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York. more
Time Frame | PFE | Sector | S&P500 |
---|---|---|---|
1-Week Return | 3.05% | -2.12% | -3% |
1-Month Return | 5.69% | -3.42% | -0.73% |
3-Month Return | -10.4% | -11.13% | 2.87% |
6-Month Return | -4.97% | -5.74% | 7.17% |
1-Year Return | -4.6% | 3.97% | 25.31% |
3-Year Return | -56.8% | 1.05% | 28.38% |
5-Year Return | -29.07% | 34.37% | 81.89% |
10-Year Return | -13.29% | 97.88% | 183.27% |
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | 5YR TREND | |
---|---|---|---|---|---|---|
Total Revenue | 51.75B | 41.91B | 81.29B | 100.33B | 58.50B | [{"date":"2019-12-31","value":51.58,"profit":true},{"date":"2020-12-31","value":41.77,"profit":true},{"date":"2021-12-31","value":81.02,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":58.3,"profit":true}] |
Cost of Revenue | 10.22B | 8.69B | 30.82B | 34.34B | 29.69B | [{"date":"2019-12-31","value":29.75,"profit":true},{"date":"2020-12-31","value":25.31,"profit":true},{"date":"2021-12-31","value":89.74,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":86.44,"profit":true}] |
Gross Profit | 41.53B | 33.22B | 50.47B | 65.99B | 28.81B | [{"date":"2019-12-31","value":62.94,"profit":true},{"date":"2020-12-31","value":50.34,"profit":true},{"date":"2021-12-31","value":76.48,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":43.66,"profit":true}] |
Gross Margin | 80.25% | 79.26% | 62.08% | 65.77% | 49.25% | [{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":98.76,"profit":true},{"date":"2021-12-31","value":77.36,"profit":true},{"date":"2022-12-31","value":81.95,"profit":true},{"date":"2023-12-31","value":61.37,"profit":true}] |
Operating Expenses | 27.61B | 24.46B | 30.23B | 28.71B | 25.45B | [{"date":"2019-12-31","value":91.33,"profit":true},{"date":"2020-12-31","value":80.89,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":94.98,"profit":true},{"date":"2023-12-31","value":84.18,"profit":true}] |
Operating Income | 15.14B | 10.63B | 24.83B | 40.03B | 3.36B | [{"date":"2019-12-31","value":37.81,"profit":true},{"date":"2020-12-31","value":26.56,"profit":true},{"date":"2021-12-31","value":62.04,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":8.39,"profit":true}] |
Total Non-Operating Income/Expense | 1.20B | (4.97B) | (3.92B) | (3.53B) | (2.89B) | [{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":-415.2,"profit":false},{"date":"2021-12-31","value":-327.82,"profit":false},{"date":"2022-12-31","value":-294.9,"profit":false},{"date":"2023-12-31","value":-241.1,"profit":false}] |
Pre-Tax Income | 17.68B | 7.50B | 24.31B | 34.73B | 1.06B | [{"date":"2019-12-31","value":50.91,"profit":true},{"date":"2020-12-31","value":21.59,"profit":true},{"date":"2021-12-31","value":70,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":3.05,"profit":true}] |
Income Taxes | 1.38B | 477.00M | 1.85B | 3.33B | (1.11B) | [{"date":"2019-12-31","value":41.59,"profit":true},{"date":"2020-12-31","value":14.33,"profit":true},{"date":"2021-12-31","value":55.65,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-33.47,"profit":false}] |
Income After Taxes | 16.30B | 7.02B | 22.46B | 31.40B | 2.17B | [{"date":"2019-12-31","value":51.9,"profit":true},{"date":"2020-12-31","value":22.36,"profit":true},{"date":"2021-12-31","value":71.52,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":6.92,"profit":true}] |
Income From Continuous Operations | 16.30B | 7.02B | 22.46B | 31.40B | 2.17B | [{"date":"2019-12-31","value":51.9,"profit":true},{"date":"2020-12-31","value":22.36,"profit":true},{"date":"2021-12-31","value":71.52,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":6.92,"profit":true}] |
Income From Discontinued Operations | 4.00M | 2.63B | (434.00M) | 6.00M | - | [{"date":"2019-12-31","value":0.15,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":-16.5,"profit":false},{"date":"2022-12-31","value":0.23,"profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Net Income | 16.27B | 7.02B | 21.98B | 31.37B | 2.12B | [{"date":"2019-12-31","value":51.87,"profit":true},{"date":"2020-12-31","value":22.38,"profit":true},{"date":"2021-12-31","value":70.06,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":6.75,"profit":true}] |
EPS (Diluted) | 2.95 | 2.72 | 4.42 | 6.63 | 1.83 | [{"date":"2019-12-31","value":44.49,"profit":true},{"date":"2020-12-31","value":41.03,"profit":true},{"date":"2021-12-31","value":66.67,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":27.6,"profit":true}] |
These ratios help you determine the liquidity of the company. Higher is better.
PFE | |
---|---|
Cash Ratio | 0.23 |
Current Ratio | 1.00 |
Quick Ratio | 0.73 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
PFE | |
---|---|
ROA (LTM) | 3.31% |
ROE (LTM) | 4.54% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
PFE | |
---|---|
Debt Ratio Lower is generally better. Negative is bad. | 0.58 |
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | 0.42 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
PFE | |
---|---|
Trailing PE | 34.36 |
Forward PE | 8.69 |
P/S (TTM) | 2.46 |
P/B | 1.59 |
Price/FCF | 24 |
EV/R | 3.43 |
EV/Ebitda | 14.70 |
PEG | 0.18 |
Pfizer Inc (PFE) share price today is $26.36
Yes, Indians can buy shares of Pfizer Inc (PFE) on Vested. To buy Pfizer Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in PFE stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.
Yes, you can purchase fractional shares of Pfizer Inc (PFE) via the Vested app. You can start investing in Pfizer Inc (PFE) with a minimum investment of $1.
You can invest in shares of Pfizer Inc (PFE) via Vested in three simple steps:
The 52-week high price of Pfizer Inc (PFE) is $31.06. The 52-week low price of Pfizer Inc (PFE) is $24.11.
The price-to-earnings (P/E) ratio of Pfizer Inc (PFE) is 34.36
The price-to-book (P/B) ratio of Pfizer Inc (PFE) is 1.59
The dividend yield of Pfizer Inc (PFE) is 6.67%
The market capitalization of Pfizer Inc (PFE) is $146.04B
The stock symbol (or ticker) of Pfizer Inc is PFE